Recurrent hbv integration targets as potential drivers in hepatocellular carcinoma

Selena Y. Lin, Adam Zhang, Jessica Lian, Jeremy Wang, Ting Tsung Chang, Yih Jyh Lin, Wei Song, Ying Hsiu Su

研究成果: Article同行評審

摘要

Chronic hepatitis B virus (HBV) infection is the major etiology of hepatocellular carcinoma (HCC), frequently with HBV integrating into the host genome. HBV integration, found in 85% of HBV-associated HCC (HBV–HCC) tissue samples, has been suggested to be oncogenic. Here, we investigated the potential of HBV–HCC driver identification via the characterization of recurrently targeted genes (RTGs). A total of 18,596 HBV integration sites from our in-house study and others were analyzed. RTGs were identified by applying three criteria: at least two HCC subjects, reported by at least two studies, and the number of reporting studies. A total of 396 RTGs were identified. Among the 28 most frequent RTGs, defined as affected in at least 10 HCC patients, 23 (82%) were associated with carcinogenesis and 5 (18%) had no known function. Available breakpoint positions from the three most frequent RTGs, TERT, MLL4/KMT2B, and PLEKHG4B, were analyzed. Mutual exclusivity of TERT promoter mutation and HBV integration into TERT was observed. We present an RTG consensus through comprehensive analysis to enable the potential identification and discovery of HCC drivers for drug development and disease management.

原文English
文章編號1294
期刊Cells
10
發行號6
DOIs
出版狀態Published - 2021 六月

All Science Journal Classification (ASJC) codes

  • 醫藥 (全部)

指紋

深入研究「Recurrent hbv integration targets as potential drivers in hepatocellular carcinoma」主題。共同形成了獨特的指紋。

引用此